LGALS3 is an efferocytosis-related biomarker and potential traditional Chinese medicine therapeutic target for diabetic kidney disease complicated with heart failure
Dunlin HU, Hui GUO, Xiaojuan WANG, Yu LI, Chi ZHANG, Xiaohu CHEN, XiaoLi NIE
Journal of Southern Medical University . 2026, (10): 2494 -2508 .  DOI: 10.12122/j.issn.1673-4254.2026.10.18